Table 4.

Relationship Between Patient-Level Performance on Emerging Measures and 1-Year Mortality

Measure	Received	One-Year Mortality
		No. of Events	Incidence, %	P Value	Unadjusted HR (95% CI)	Adjusted HR (95% CI)*
Any beta-blocker	Yes	1875	30.7	< .001	0.67 (0.61–0.74)	0.75 (0.69–0.83)
	No	597	41.8
Evidence-based beta-blocker	Yes	1493	30.8	< .001	0.80 (0.74–0.86)	0.82 (0.76–0.89)
	No	979	36.6
Warfarin	Yes	1272	31.2	< .001	0.70 (0.64–0.76)	0.79 (0.72–0.86)
	No	1657	41.2
Aldosterone antagonist	Yes	362	28.7	.06	0.90 (0.79–1.03)	0.91 (0.80–1.04)
	No	1759	31.2
Implantable cardioverter-defibrillator	Yes	266	28.4	.30	0.93 (0.79–1.11)	0.97 (0.83–1.12)
	No	1652	30.3
Disease management	Yes	748	28.8	.39	1.03 (0.95–1.12)	1.07 (0.98–1.16)
	No	4546	27.7

Abbreviations: HR, hazard ratio; CI, confidence interval.